Here, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich detail some of the cold chain for cell therapies is beholden to regulatory requirements.
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Please enter your email address and create a password to access the full content, Or
log in to your account to continue.
Please tell us more about you so that we can customize our newsletters to your specific interests: